Early use of alendronate as a protective factor against the development of glucocorticoid-induced bone loss in childhood-onset rheumatic diseases: a cross-sectional study

BACKGROUND: Bisphosphonates are recommended for use as first-line therapy for the prevention and treatment of glucocorticoid-induced osteoporosis in adults. However, the appropriate usage of bisphosphonates for the prevention or treatment of glucocorticoid-induced osteoporosis in children remains un...

Descripción completa

Detalles Bibliográficos
Autores principales: Inoue, Yuzaburo, Mitsunaga, Kanako, Yamamoto, Takeshi, Chiba, Koki, Yamaide, Fumiya, Nakano, Taiji, Morita, Yoshinori, Yamaide, Akiko, Suzuki, Shuichi, Arima, Takayasu, Yamaguchi, Ken-ichi, Tomiita, Minako, Shimojo, Naoki, Kohno, Yoichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6006935/
https://www.ncbi.nlm.nih.gov/pubmed/29914510
http://dx.doi.org/10.1186/s12969-018-0258-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6006935/
https://www.ncbi.nlm.nih.gov/pubmed/29914510
http://dx.doi.org/10.1186/s12969-018-0258-5

Ejemplares similares